{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:20:23Z","timestamp":1791469223307,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204202"],"award-info":[{"award-number":["82204202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8240131478"],"award-info":[{"award-number":["8240131478"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA1506403"],"award-info":[{"award-number":["2023YFA1506403"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2804104"],"award-info":[{"award-number":["2022YFC2804104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005953","name":"Society of Hong Kong Scholars","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ24H300012"],"award-info":[{"award-number":["LQ24H300012"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bioorg.2025.108854","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T14:48:21Z","timestamp":1754750901000},"page":"108854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Rational discovery of novel tetrahydroisoquinoline-indole derivatives as potent P-glycoprotein inhibitor against multidrug resistance in MCF-7\/ADR cell"],"prefix":"10.1016","volume":"164","author":[{"given":"Zhikun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhou","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108854_bb0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.aav9406","article-title":"Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors","volume":"364","author":"Dastvan","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.108854_bb0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/med.21739","article-title":"Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp)","volume":"41","author":"Zhang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.108854_bb0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/bjc.1988.291","article-title":"The multidrug resistance phenotype","volume":"58","author":"Kaye","year":"1988","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108854_bb0020","first-page":"710","article-title":"Recent advances in the search of BCRP- and dual P-gp\/BCRP-based multidrug resistance modulators","volume":"2","author":"Dei","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.bioorg.2025.108854_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.trecan.2015.11.003","article-title":"Cancer evolution and the limits of predictability in precision Cancer medicine","volume":"2","author":"Lipinski","year":"2016","journal-title":"Trends Cancer."},{"key":"10.1016\/j.bioorg.2025.108854_bb0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature18325","article-title":"Replication fork stability confers chemoresistance in BRCA-deficient cells","volume":"535","author":"Ray Chaudhuri","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108854_bb0035","first-page":"1159","article-title":"Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan","volume":"45","author":"Meisenberg","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.108854_bb0040","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.108854_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bse0500209","article-title":"The controversial role of ABC transporters in clinical oncology","volume":"50","author":"Tamaki","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/BST0330241","article-title":"ABC transporters in the balance: is there a role in multidrug resistance?","volume":"33","author":"Polgar","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bioorg.2025.108854_bb0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10555-012-9402-8","article-title":"Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?","volume":"32","author":"Yu","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bioorg.2025.108854_bb0060","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.ejmech.2017.10.041","article-title":"Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance","volume":"143","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105075","article-title":"Rational design of phenyl thiophene (pyridine) derivatives that overcome P-glycoprotein mediated MDR in MCF-7\/ADR cell","volume":"114","author":"Li","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jare.2014.11.008","article-title":"P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: a review","volume":"6","author":"Abdallah","year":"2015","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bioorg.2025.108854_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114231","article-title":"Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel","volume":"233","author":"Shi","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116207","article-title":"Design, synthesis, and bioactivity evaluation of novel indole-selenide derivatives as P-glycoprotein inhibitors against multi-drug resistance in MCF-7\/ADR cell","volume":"268","author":"Yang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0085","first-page":"2818","article-title":"Reversal of multidrug resistance by verapamil and modulation by alpha1-ccid glycoprotein in wild-type and multidrug-resistant Chinese hamsterovary cell lines","volume":"50","author":"Chatterjee","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108854_bb0090","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1158\/1078-0432.CCR-04-1725","article-title":"Cyclosporin a is a broad-spectrum multidrug resistance modulator","volume":"11","author":"Qadir","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108854_bb0095","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.bjc.6990485","article-title":"BIRICODAR (VX-710; IncelTM): an effective chemosensitizer in neuroblastoma","volume":"80","author":"Yanagisawa","year":"1999","journal-title":"Brit. J. Cancer."},{"key":"10.1016\/j.bioorg.2025.108854_bb0100","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/0006-2952(87)90139-0","article-title":"Action of calcium antagonists on multidrug resistant cells. Specific cytotoxicity independent of increased cancer drug accumulation","volume":"36","author":"Cano-Gauci","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108854_bb0105","first-page":"177B","article-title":"Blockade of P-gp function in acute myeloid leukemia bone marrow cells after zosuquidar (LY335979) administration","volume":"98","author":"Green","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2025.108854_bb0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","article-title":"Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein","volume":"10","author":"Thomas","year":"2003","journal-title":"Cancer Control"},{"key":"10.1016\/j.bioorg.2025.108854_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202412649","article-title":"Highly potent and intestine specific P-glycoprotein inhibitor to enable oral delivery of Taxol","volume":"63","author":"Zhou","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108854_bb0120","doi-asserted-by":"crossref","first-page":"14895","DOI":"10.1021\/acs.jmedchem.1c01452","article-title":"Discovery of new 4-indolyl quinazoline derivatives as highly potent and orally bioavailable P-glycoprotein inhibitors","volume":"64","author":"Yuan","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0125","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1021\/acs.jmedchem.0c00337","article-title":"Discovery of potent inhibitors against P-glycoprotein-mediated multidrug resistance aided by late-stage functionalization of a 2-(4-(Pyridin-2-yl)phenoxy)pyridine analogue","volume":"63","author":"Ma","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0130","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1021\/acs.jmedchem.2c01999","article-title":"Novel benzo five-membered heterocycle derivatives as P-glycoprotein inhibitors: design, synthesis, molecular docking, and anti-multidrug resistance activity","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0135","doi-asserted-by":"crossref","first-page":"26245","DOI":"10.1073\/pnas.2010264117","article-title":"Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1","volume":"117","author":"Nosol","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2025.108854_bb0140","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1016\/S0040-4039(01)95429-2","article-title":"A new stereospecific cross-coupling by the palladium-catalyzed reaction of 1-alkenylboranes with 1-alkenyl or 1-alkynyl halides","volume":"20","author":"Miyaura","year":"1979","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2025.108854_bb0145","first-page":"1","article-title":"Design, synthesis, and action mechanism of 1,3-benzodioxole derivatives as potent auxin receptor agonists and root growth promoters","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.bioorg.2025.108854_bb0150","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00344-019-10030-1","article-title":"Computational-aided discovery of novel 1,3-Benzodioxole plant growth retardants","volume":"39","author":"Wang","year":"2020","journal-title":"J. Plant Growth Regul."},{"key":"10.1016\/j.bioorg.2025.108854_bb0155","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/ci500467k","article-title":"iLOGP: a simple, robust, and efficient description of n -octanol\/water partition coefficient for drug design using the GB\/SA approach","volume":"54","author":"Daina","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2025.108854_bb0160","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2387415","article-title":"Design, synthesis, and biological evaluation of (thio)urea derivatives as potent Escherichia coli \u03b2-glucuronidase inhibitors","volume":"39","author":"Xu","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0165","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ejmech.2016.09.070","article-title":"Extending the structure\u2212activity relationship study of marine natural ningalin B analogues as P-glycoprotein inhibitors","volume":"125","author":"Yang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0170","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/10286020.2015.1047772","article-title":"Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6","volume":"17","author":"Sun","year":"2015","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2025.108854_bb0175","first-page":"9789","article-title":"Total syntheses of Bryostatins. Syntheses of two ring-expanded Bryostatin analogues and development of a new-generation strategy to access the C7-C27 fragment","volume":"17","author":"Trost","year":"2011","journal-title":"Chem. Weinh. Bergstr. Ger."},{"key":"10.1016\/j.bioorg.2025.108854_bb0180","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1021\/ol801895y","article-title":"A new Total synthesis of patellamide a","volume":"10","author":"Garc\u00eda-Reynaga","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2025.108854_bb0185","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1016\/j.tet.2003.07.020","article-title":"Kendarimide a, a novel peptide reversing P-glycoprotein-mediated multidrug resistance in tumor cells, from a marine sponge of Haliclona sp","volume":"60","author":"Aoki","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.108854_bb0190","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1158\/1535-7163.MCT-11-0252","article-title":"Trabectedin and its C subunit modified analogue PM01183 attenuate nucleotide excision repair and show activity toward platinum-resistant cells","volume":"10","author":"Soares","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2025.108854_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113336","article-title":"Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7\/ADR cell","volume":"216","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0200","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejmech.2018.04.012","article-title":"Synthesis and biological evaluation of 2,5-disubstituted furan derivatives as P-glycoprotein inhibitors for doxorubicin resistance in MCF-7\/ADR cell","volume":"151","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112555","article-title":"New seco-DSP derivatives as potent chemosensitizers","volume":"204","author":"Wan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112331","article-title":"Novel curcumin derivatives as P-glycoprotein inhibitors: molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin","volume":"198","author":"Sagnou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0215","doi-asserted-by":"crossref","first-page":"14655","DOI":"10.1021\/acs.jmedchem.2c01175","article-title":"New dual P-glycoprotein (P-gp) and human carbonic anhydrase XII (hCA XII) inhibitors as multidrug resistance (MDR) reversers in Cancer cells","volume":"65","author":"Braconi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25071748","article-title":"Dual P-glycoprotein and CA XII inhibitors: a new strategy to reverse the P-gp mediated multidrug resistance (MDR) in cancer cells","volume":"25","author":"Teodori","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108854_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115092","article-title":"Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7\/ADR cell","volume":"248","author":"Yang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108854_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115462","article-title":"Discovery of 2,5-disubstituted furan derivatives featuring a benzamide motif for overcoming P-glycoprotein mediated multidrug resistance in MCF-7\/ADR cell","volume":"257","author":"Yang","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:28:54Z","timestamp":1778632134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825007345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":46,"alternative-id":["S0045206825007345"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108854","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational discovery of novel tetrahydroisoquinoline-indole derivatives as potent P-glycoprotein inhibitor against multidrug resistance in MCF-7\/ADR cell","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108854"}}